Applications Published 25 October 2000
Published: 25-May-2001
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Pharmaceutical compsns and methods for the treatment of failing myocardial tissue
Feldman, Arthur 1045636*Decorated red blood cells
Trustees of Boston University 1045637*Saccharide-basde matrix comprising a maltodextrin, a gelling agent and a sugar
Bioavail Technologies 1045648*Container for an inhalation anaesthetic
Abbott Laboratories 1045686*Lipomatrix preparation
Biomira 1045688*Synthesis of phenstatin and prodrugs thereof
Arizona Board of Regents 1045689*Benzenesulphonamide inhibitors of PDE-IV and their therapeutic use
Warner-Lambert 1045690*Statin-carboxylalkylether combinations
Warner-Lambert 1045691*Aminophenoxyacetic acid derivatives as neuroprotectants
Suntory 1045693*method of increasing bone volume using non-naturally-occurring FP selective agents
Procter & Gamble 1045694*Oral oil sorbing compsn
West Pharmaceutical Services Drug Delivery and Clinical Research Centre 1045696*Extension of cellular lifespan, methods and reagents
Cold Spring Harbour Laboratory 1045697*Patient-specific white blood cell malignancy vaccine from membrane-proteoliposomes
Biomira 1045698*Genetic immunisation with co-delivery of nucleic acid and cytokines in a single vehicle
The Johns Hopkins University 1045699*Oral delivery of nucleic acid vaccines by particulate complexes
The Johns Hopkins University 1045700*Methods of using human receptor protein 4-1BB
Advanced Research and Technology 1045701*Methods of controlling cell differentiation and growth using a fusion protein and a drug
The Board of Trustees of the Leland Stanford Junior University 1045702*Stabilisation of lipid:DNA formulations during nebulisation.
Research Development Corporation 1045703*Method for quenching pathogen inactivators in biological materials
Cerus Corp 1045704*Absorbent polymer compsns having high sorption capacities under an applied pressure and improved integrity in the swollen state
Procter & Gamble 1045705*Method for inhaling powdery substances
AstraZeneca 1045711*Sonophoretic enhanced transdermal transport
Sontra Medical; Massachusetts Institute of Technology 1045614*Method for producing mass-coded combinatorial libraries
Neogenesis 1045819*Process for the preparation of TFPX-dichloride
Alpha Metals 1045821*Certain diterpenes and extracts or concentrates of Curcuma amada containing them for use as medicaments
Ida Developments 1045822*Process for making certain benzoic acid compsns
Procter & Gamble 1045823*Novel polyethoxylated castor oil, proces of making the same, and formulations thereof
Schein Pharmaceutical 1045825*Process for the preparation of isopropyl-methyl-2-(3-N-propooxyphenoxy)ethylamine
AstraZeneca 1045826*Method for producing (s,S')-N,N'-ethylenediamine disuccinic acid, analogous compounds or salts thereof
BASF 1045827*Method for producing highly pure tetrasodium salt of ethylenediaminetetracetic acid
Tong Suh Petrochemical 1045828*Alpha-aminoamide derivatives useful as analgesic agents
Newron Pharmaceuticals 1045830*Solid supported synthesis of hydroxamic acids
Procter & Gamble 1045831*Novel urethanes, thio and dithio analogues, the salts thereof, medicaments containing sadi compounds, use and method for the production thereof
Boehringer Ingelheim 1045832*2,3-substituted indole compounds as COX-2 inhibitors
Pfizer 1045833*4(3)substituted-4(3)-aminomethyl(thio)pyran or -piperidine derivatives (gabapentin analogues), their preparation and their use in the treatment of neurological disorders
Warner-Lambert 1045834*Catalyst and method for amide formulation
Eli Lilly 1045835*Pyridones as SRC family SH2 domain inhibitors
Boheringer Ingelheim Pharmaeuticals 1045836*Monomeric and dimeric arylisoquinoline derivatives thereof
The Government of the United States of America, as represented by the Secretary of State of the Department of Health and Human Services 1045837*1,4,7,10-tetraazacyclododecane-1,4-diacetic acid
Bracco 1045838*Novel amines as pharmaceutical agents
Warner-Lambert 1045839*Hydrolipidemic benzothiazepine compounds
Glaxo Group 1045840*Novel genipin derivative having liver protection activity
Choongwae Pharma Corp 1045841*Method of use and compsns for benzylidene- and cinnamylidene-anabaseines
University of Florida 1045842*N-oxides of heterocyclic compounds with TNF and PDE-IV inhibiting activity
Darwin Discovery 1045845*Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof
LG Chemical 1045846*Purine derivatives having phosphodiesterase IV inhibition activity
Euro-Celtique 1045849*Purine compounds having PDE-IV inhibitory activity and methods of synthesis
Euro-Celtique 1045850*Substituted porphyrins
Duke University 1045851*Process for the preparation of cefpodoxim proxetil diastereoisomers
Biochemie 1045852*Synthesis of combretastatin A-4 prodrugs and trans-isomers thereof
Arizona Board of Regents 1045853*Preparation of phosphonic acid derivatives
Rhodia Consumer Specialties 1045854*Novel aromatic amides, preparation method and application as medicines
Hoechst MarionRoussel 1045856*Multiple drug resistance gene ATRC of Aspergillus nidulans
Eli Lilly 1045857*Anti-cryptococcal peptides
Arizona Board of Regents 1045858*Novel surface protein of Neisseria meningitidis
The University of Queensland 1045859*Methods and compsns for treating and diagnosing insulin related disorders
Duckworth, William Clifford 1045860*Antibody/receptor targeting moiety for enhanced delivery of armed ligand
Center for Molecular Medicine 1045861*Polypeptides, DNA coding therefor, formulations thereof, and their use in inhibiting factor XII activation
Bio-Discovery 1045862*Detoxification of active pharmaceutical substances using cyclodextrine oligomers
Ceramoptec 1045863*Microsuspension polymer containing acid groups
BASF 1045864*
